Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) General Information

Description

Manufacturer of Covid-19 vaccine based in Abu Dhabi, United Arab Emirates. The joint venture intends to have a production capacity of 200 million doses per annum across three filling lines and five automated packaging lines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Khalifa Industrial Zone
  • Abu Dhabi United Arab Emirates
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Khalifa Industrial Zone
  • Abu Dhabi United Arab Emirates

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG)‘s full profile, request access.

Request a free trial

Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG)‘s full profile, request access.

Request a free trial

Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) FAQs

  • When was Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) founded?

    Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) was founded in 2021.

  • Where is Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) headquartered?

    Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) is headquartered in Abu Dhabi, United Arab Emirates.

  • What industry is Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) in?

    Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG)’s primary industry is Pharmaceuticals.

  • Is Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) a private or public company?

    Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) is a Private company.

  • What is Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG)’s current revenue?

    The current revenue for Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG) is .

  • Who are Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG)’s investors?

    G42 and Sinopharm Group have invested in Hayat-Vax Vaccine Manufacturing (G42 / Sinopharm CNBG).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process